WHO ICTRP trial
An open-label, one-period, one-treatment study which objective is to evaluate…
EUCTR2005-000361-19-DK · EU Clinical Trials Register · Not Recruiting
Key facts
| Trial ID | EUCTR2005-000361-19-DK |
|---|---|
| Public title | An open-label, one-period, one-treatment study which objective is to evaluate the time course of the antiproteinuric and blood pressure lowering effect of renin inhibition with Aliskiren in patients with Type 2 diabetes suffering from incipient and/or established nephropathy |
| Scientific title | An open-label, one-period, one-treatment study which objective is to evaluate the time course of the antiproteinuric and blood pressure lowering effect of renin inhibition with Aliskiren in patients with Type 2 diabetes suffering from incipient and/or established nephropathy |
| Primary sponsor | Novartis Pharma Services AG |
| Registry | EU Clinical Trials Register |
| Recruitment status | Not Recruiting |
| Study type | Interventional clinical trial of medicinal product |
| Countries | Denmark |
| Conditions | Hypertension |
| Interventions | Product Name: Aliskiren Product Code: SPP100 Pharmaceutical Form: Tablet INN or Proposed INN: Aliskiren CAS Number: 173334-58-2 Current Sponsor code: SPP100 Concentration unit: mg milligram(s) Concentration type: equal Concentration number… |
| Registration date | Apr 15, 2005 |
| Target size | 18 |
| Secondary IDs | CSPP100A2242 |
| Registry page | clinicaltrialsregister.eu |
At a glance
- No Results available
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About WHO ICTRP trial registrations
The WHO ICTRP combines trial registrations from primary registries worldwide into a single searchable index. Contact and ethics-committee details are not shown here.
Source: World Health Organization (WHO), International Clinical Trials Registry Platform (ICTRP) · Source date: